X
X4 Pharmaceuticals D
D
XFOR
3.92000
USD
0.04
(1.03%)
مغلق
حجم التداول
19,703
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
342,751,817
العنوان: X4 Pharmaceuticals Inc
القطاع: Healthcare
الصناعة: Biotechnology
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.